Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 15, 2016 - Issue 3
Submit an article Journal homepage
477
Views
4
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Olanzapine pamoate for the treatment of schizophrenia – a safety evaluation

Ludovic SamalinCHU Clermont-Ferrand, University of Auvergne, Clermont-Ferrand, France;Institute of Neuroscience, Hospital Clinic, University of Barcelona, Barcelona, SpainCorrespondence[email protected]
,
Ricardo GarayPharmacology & Therapeutics, Craven, France
,
Ahcène AmegPharmacology & Therapeutics, Craven, France
&
Pierre-Michel LlorcaCHU Clermont-Ferrand, University of Auvergne, Clermont-Ferrand, France
Pages 403-411 | Received 11 Dec 2015, Accepted 11 Jan 2016, Published online: 19 Feb 2016

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Amir M Meftah, Elizabeth Deckler, Leslie Citrome & Joshua T Kantrowitz. (2020) New discoveries for an old drug: a review of recent olanzapine research. Postgraduate Medicine 132:1, pages 80-90.
Read now

Articles from other publishers (3)

Jason Seebaluck, Michael A. Downes, Jared Brown, Keith Harris, Katherine Z. Isoardi & Betty S. Chan. (2022) Case series profile of olanzapine post‐injection delirium/sedation syndrome. British Journal of Clinical Pharmacology 89:2, pages 903-907.
Crossref
Marit Tveito, Robert L. Smith, Espen Molden, Tore Haslemo, Helge Refsum, Cecilie Hartberg, Christoph U. Correll & Gudrun Høiseth. (2018) Age Impacts Olanzapine Exposure Differently During Use of Oral Versus Long-Acting Injectable Formulations. Journal of Clinical Psychopharmacology 38:6, pages 570-576.
Crossref
F. Chartier, F. Rouillon, L. Berggren, I. Jamonneau, B. Falissard & P.M. Llorca. (2017) Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation. L'Encéphale 43:4, pages 303-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.